Dr. Ghulam Saydain, MD

Dr. Saydain practices at Dmc Sinai - Grace Hospital in Detroit, Michigan.

Dr. Saydain's NPI, 1154368645, was assigned on June 1, 2006. Dr. Saydain holds Michigan license 4301084958.

Dr. Saydain's primary practice is Dmc Sinai - Grace Hospital, at 6071 W Outer Dr, Detroit, MI 48235 in Wayne County. The practice phone is (313) 966-2026.

Dr. Saydain's primary practice is Dmc Sinai - Grace Hospital in Detroit, Michigan. Dr. Saydain is also affiliated with DMC Harper University Hospital. The medical group on file is Wayne Health. Dmand AI also links Dr. Saydain to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saydain practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Saydain's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Saydain is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Saydain is licensed in Michigan.

CMS data shows 521 Medicare services from Dr. Saydain across 9 procedure codes in 2024, for 179 Medicare patients. Medicare paid $41,034 for them.

CMS counts 179 Medicare patients who saw Dr. Saydain in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 73% are also on Medicaid. Their average risk score is 3.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saydain's median patient age at 63, with 59% women.

In 2024, Dr. Saydain wrote 1,854 Medicare Part D claims for 210 patients. 40% of them were for generic drugs. CMS names the drug for 1,748 of them, across 32 drugs with 11 or more claims each, at $2,281,304 in total drug cost. In 2023, CMS named 1,277 claims across 28 drugs.

Dr. Saydain accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Saydain, published from 2009 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Hospital Mortality, Percutaneous Coronary Intervention and Emergency Service, Hospital. Dr. Saydain has published most often in Cureus. Dr. Saydain's most frequent co-authors are Mohammed M. Uddin, Ayman Omar Soubani, MD and Waqas T. Qureshi, MBBS, MD.

CMS Open Payments shows 78 general payments to Dr. Saydain from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 38% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $5,847.